Jérôme Kluza Selected Research

sampangine

11/2005	Induction of apoptosis by the plant alkaloid sampangine in human HL-60 leukemia cells is mediated by reactive oxygen species.
12/2003	Apoptosis induced by the alkaloid sampangine in HL-60 leukemia cells: correlation between the effects on the cell cycle progression and changes of mitochondrial potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jérôme Kluza Research Topics

Disease

8	Leukemia 03/2006 - 04/2002
6	Neoplasms (Cancer) 01/2022 - 04/2002
4	Melanoma (Melanoma, Malignant) 01/2014 - 04/2002
2	Leukemia P388 03/2006 - 05/2004
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021
1	Type 2 Diabetes Mellitus (MODY) 07/2015
1	Prostatic Neoplasms (Prostate Cancer) 04/2005
1	Colonic Neoplasms (Colon Cancer) 09/2004
1	Adenocarcinoma 09/2004
1	Cardiotoxicity 09/2004
1	Breast Neoplasms (Breast Cancer) 09/2004
1	Experimental Melanoma 04/2002

Drug/Important Bio-Agent (IBA)

4	AlkaloidsIBA 03/2006 - 12/2003
4	DNA (Deoxyribonucleic Acid)IBA 02/2006 - 12/2003
3	Antineoplastic Agents (Antineoplastics)IBA 03/2006 - 04/2002
2	lamellarin DIBA 03/2006 - 04/2005
2	PoisonsIBA 03/2006 - 04/2005
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 03/2006 - 04/2005
2	CamptothecinIBA 03/2006 - 04/2005
2	Pharmaceutical PreparationsIBA 02/2006 - 09/2004
2	sampangineIBA 11/2005 - 12/2003
2	Antimalarials (Antimalarial Agents)IBA 11/2005 - 12/2003
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	venetoclaxIBA 11/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 07/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2015
1	GoldIBA 01/2014
1	PM031379IBA 03/2006
1	tafluposideIBA 02/2006
1	Etoposide (VP 16)FDA LinkGeneric 02/2006
1	Podophyllotoxin (Condylox)FDA LinkGeneric 02/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2005
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2005
1	lipoarabinomannan (LAM)IBA 04/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2004
1	Fluorescent Dyes (Fluorescent Probes)IBA 09/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2004
1	PeroxidesIBA 09/2004
1	AnthracyclinesIBA 09/2004
1	CaspasesIBA 09/2004
1	AnthraquinonesIBA 09/2004
1	ascidideminIBA 12/2003
1	burasaineIBA 12/2003
1	Acronine (Acronycine)IBA 04/2002
1	S 23906-1IBA 04/2002

Therapy/Procedure

1	Therapeutics 11/2021
1	Aftercare (After-Treatment) 12/2003